HealthcareServices

Cardiogenomics Market Size and Demand Forecast 2026–2030

February 20, 2026February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the cardiogenomics market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Cardiogenomics Market between 2026 and 2030?

The cardiogenomics market has experienced substantial growth in its size over recent years. The market is forecast to expand from $1.74 billion in 2025 to $2.02 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 15.7%. Historically, this growth has been fueled by the increasing prevalence of cardiovascular diseases, advancements in genetic testing technologies, expansion in clinical genomics research, broader availability of molecular diagnostics, and a heightened awareness of inherited heart conditions.

The cardiogenomics market is anticipated to experience substantial expansion over the coming years. This market is projected to reach $3.57 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.4%. Factors contributing to this growth during the forecast period include a heightened need for individualized cardiac treatment, the broadening of precision medicine programs, increased funding for genomic studies, wider acceptance of AI-powered genomic analysis, and a greater incorporation of genomics into standard cardiology procedures. Key trends anticipated for the forecast period encompass the increased application of genetic risk assessment in cardiology, a surge in the utilization of next-generation sequencing for heart disease investigations, the evolving integration of bioinformatics platforms, the expansion of customized cardiovascular treatment methods, and a stronger emphasis on preemptive genomic screening.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28156&type=smp

Which Drivers Are Expected To Impact The Cardiogenomics Market During The Forecast Period?

The anticipated expansion of the cardiogenomics market is linked to the growing need for personalized medicine. Personalized medicine involves a healthcare strategy that customizes prevention, diagnosis, and treatment based on an individual’s genetic makeup, environmental influences, and lifestyle choices. The rise of personalized medicine is propelled by genomics advancements, which facilitate a more profound comprehension of individual genetic differences, leading to more accurate and focused treatments that enhance patient results and minimize experimental approaches in therapies. Cardiogenomics aids personalized medicine through the application of genetic understanding to adapt the prevention, diagnosis, and treatment of cardiovascular disease to a person’s distinct genetic profile. An example illustrates this: in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the FDA sanctioned 16 new personalized treatments for rare disease patients, an increase from six in 2022. Among the personalized treatments newly approved for 2023 were also seven cancer drugs and three for other diseases and conditions. Consequently, the escalating demand for personalized medicine is fueling the expansion of the cardiogenomics market.

Which Segments Are Driving Activity In The Cardiogenomics Market?

The cardiogenomics market covered in this report is segmented –

1) By Product Type: Testing Kits, Reagents, Instruments, Software, Services

2) By Technology: Next-Generation Sequencing, Polymerase Chain Reaction, Microarray, Other Technologies

3) By Application: Congenital Heart Diseases, Cardiomyopathies, Arrhythmias, Coronary Artery Disease, Other Applications

4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Other End-Users

Subsegments:

1) By Testing Kits: PCR (Polymerase Chain Reaction) kits, Microarray kits, NGS (Next Generation Sequencing) kits

2) By Reagents: Enzymes, Probes, Buffers

3) By Instruments: Sequencers, Genotyping instruments, Microarray Scanners

4) By Software: Data Analysis Software, Reporting Platforms, Bioinformatics Tools

5) By Services: Genetic Testing Services, Counseling Services, Data Analysis Services

What Trends Are Driving The Growth Trajectory Of The Cardiogenomics Market?

Leading companies in the cardiogenomics market are concentrating on creating innovative solutions, such as oncogenomics, to improve the early detection and personalized treatment of cardiovascular-related cancers. Oncogenomics involves the study of genes linked to cancer and their mutations to understand the development and progression of cancer, and to formulate targeted therapies and personalized treatment approaches. For example, in April 2025, Fortis Healthcare Ltd., an India-based healthcare company, inaugurated a Fortis Institute of Genomic Medicine in India, aiming to advance genetic research and personalized medicine. This initiative transforms patient care by enabling early disease discovery, precise diagnosis, and individualized treatment across specialties like oncology, cardiology, and neurology. It also supports targeted therapies, enhances treatment results, and provides preventative care for hereditary conditions. The institute’s goal is to advance precision medicine using a multidisciplinary team and cutting-edge technologies, thereby making healthcare more customized and effective for Indian patients.

Which Leading Companies Dominate The Cardiogenomics Market Share?

Major companies operating in the cardiogenomics market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings (Labcorp), Quest Diagnostics Incorporated, Illumina Inc., QIAGEN N.V., Myriad Genetics Inc., ARUP Laboratories, BGI Genomics Co. Ltd., Invitae Corporation, GeneDx Inc., Helix OpCo LLC, SOPHiA GENETICS SA, Baylor Genetics, Blueprint Genetics, Novogenia GmbH, Veritas Genetics, Dante Genomics, Gene by Gene Ltd., GENinCode Plc., UAB Cardiogenomics Clinic

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/cardiogenomics-global-market-report

How Does The Cardiogenomics Market Perform Across Major Global Regions?

North America was the largest region in the cardiogenomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiogenomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Cardiogenomics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28156&type=smp

Browse Through More Reports Similar to the Global Cardiogenomics Market 2026, By The Business Research Company

Cardiac Mapping Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-mapping-global-market-report

Cardiac Biomarkers Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report

Pharmacogenomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacogenomics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795